ACTRN12607000428460进行中（未招募）不适用
Randomised, double-blind, placebo controlled study to assess efficacy of topical nicotinamide in the treatment and prevention of actinic keratosis.
Royal prince Alfred ( Provides infrastructural support)0 个研究点目标入组 32 人开始时间: 2007年8月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 -2147483648 N/A（—）
- 性别
- All
入选标准
- •Symmetrically distributed non-hyperkeratotic AKs on face / scalp/ upper limbs.Minimum of 4 AKs in one or more treatment areas.Patients have received no other treatments for AKs within the last month.
排除标准
- •Pregnant or lactating Taking immunosuppressive or photosensitising medications Taking nicotinamide or other vitamin supplements Patients unable to attend for regular follow up Patients with active dermatitis in the treatment areas.
研究者
相似试验
招募中
不适用
Randomised, double-blind, placebo controlled study to assess efficacy of oral nicotinamide in the treatment and prevention of actinic keratosesActinic KeratosesSkin - Dermatological conditionsACTRN12609000490279Royal Prince Alfred (provide infrastructural support)50
进行中（未招募）
1 期
Effects of EPA-FFA on polypectomy in familial adenomatous polyposis.Familial Adenomatous Polyposis (FAP)MedDRA version: 20.1Level: LLTClassification code 10059327Term: Familial adenomatous polyposisSystem Organ Class: 100000004850EUCTR2017-002809-34-CZSLA Pharma (UK) Ltd204
进行中（未招募）
不适用
Randomised, double-blind, placebo-controlled study to investigate the efficacy and safety of a herbal combination product, Eviprostat N, in the treatment of moderate LUTS associated with benign prostatic hyperplasia” - EVE 2004/01Patients with moderate LUTS (Lower Urinary Tract Symptoms) associated with benign prostatic hyperplasiaMedDRA version: 7.0Level: LLTClassification code 10004446EUCTR2004-002901-57-DEPharmazeutische Fabrik Evers & Co. GmbH326
进行中（未招募）
1 期
Effects of EPA-FFA on polypectomy in familial adenomatous polyposis.EUCTR2017-002809-34-DKSLA Pharma UK Ltd204
进行中（未招募）
1 期
Clinical trial to compare APD421 (amisulpride) against a placebo for the treatment of patients feeling sick or being sick after an operation, who have not previously been given treatment for the condition.EUCTR2015-002041-59-DEAcacia Pharma Ltd580